US 7309692
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
granted A61KA61K38/00A61K48/00
Quick answer
US patent 7309692 (Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1) held by The Board of Regents of the University of Texas System expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K48/00, A61P, A61P35/00